Non-motor symptoms in Chinese Parkinson’s disease patients with and without LRRK2 G2385R and R1628P variants

被引:0
|
作者
Da-Wei Li
Zhuqin Gu
Chaodong Wang
Jinghong Ma
Bei-Sha Tang
Sheng-Di Chen
Piu Chan
机构
[1] Xuanwu Hospital of Capital Medical University,Department of Neurology, Neurobiology and Geriatrics, National GCP Clinical Trial Center on Neurodegenerative Disease, Beijing Institute of Geriatrics
[2] Xuanwu Hospital of Capital Medical University,Department of Neurology
[3] Ministry of Education and Key Laboratory for Parkinson’s Disease,Key Laboratory of Neurodegenerative Disease
[4] Beijing,Department of Neurology
[5] Xiangya Hospital of Central South University,Institute of Neurology
[6] Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine,undefined
来源
Journal of Neural Transmission | 2015年 / 122卷
关键词
LRRK2 variants; Non-motor symptoms; NMSQuest; Nocturia; Parkinson’s disease;
D O I
暂无
中图分类号
学科分类号
摘要
Non-motor symptoms (NMS) are common among patients with Parkinson’s disease (PD). However, reports on NMS in Chinese PD population are scarce. Little is known about NMS in patients with Asian specific leucine-rich repeat kinase 2 (LRRK2) variants in G2385R and R1628P. This study aimed to elucidate the clinical characteristics of NMS in Chinese PD patients and to ascertain if there were differences in NMS between PD patients with and without LRRK2 variants. A multicenter, observational study was conducted with 1,225 sporadic PD (sPD) patients recruited from a PD cohort of the Chinese National Consortium on neurodegenerative diseases, 163 participants had the LRRK2 variants. The Non-motor Symptom Questionnaire (NMSQ) was used to screen for the presence of NMS. This study found the majority of sPD patients (97.6 %) had at least one NMS. A mean of 8.72 NMS (SD = 5.43) was reported per patient. Forgetfulness, constipation and daytime sleepiness were found to be the most frequent NMS. Moreover, the number of NMS was positively correlated with the age, disease duration, Hoehn & Yahr stage and the motor scores of the unified Parkinson’s disease rating scale. Although no discrepancy was found in the number of NMS between sPD patients with and without LRRK2 variants, nocturia was less common in LRRK2 variants carriers than in non-carriers (P = 0.045). NMS appear to be prevalent in Chinese sPD population. There are no differences in the NMS phenotype between LRRK2 and no LRRK2 patients.
引用
收藏
页码:661 / 667
页数:6
相关论文
共 50 条
  • [21] LRRK2 R1628P contributes to Parkinson's disease susceptibility in Chinese Han populations from mainland China
    Yu, Lihua
    Hu, Fayun
    Zou, Xiaoyi
    Jiang, Yi
    Liu, Yan
    He, Xianghua
    Xi, Jing
    Liu, Ling
    Liu, Zhuolin
    He, Li
    Xu, Yanming
    BRAIN RESEARCH, 2009, 1296 : 113 - 116
  • [22] Sex effects on clinical features in LRRK2 G2385R carriers and non-carriers in Parkinson's disease
    Shi-Shuang Cui
    Rao Fu
    Juan-Juan Du
    Yi-Qi Lin
    Pei Huang
    Chao Gao
    Hai-Yan Zhou
    Sheng-Di Chen
    BMC Neuroscience, 22
  • [23] Confirmation of the association between LRRK2 R1628P variant and susceptibility to Parkinson's disease in the Thai population
    Pulkes, Teeratorn
    Papsing, Chutima
    Thakkinstian, Ammarin
    Pongpakdee, Sunsanee
    Kulkantrakorn, Kongkiat
    Hanchaiphiboolkul, Suchat
    Tiamkao, Somsak
    Boonkongchuen, Pairoj
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (09) : 1018 - 1021
  • [24] Effect of LRRK2 G2385R Variant on Subthalamic Deep Brain Stimulation Efficacy in Parkinson's Disease in a Han Chinese Population
    Chen, Si
    Liu, Hong
    Wu, Qian-qian
    Xu, Shu-jun
    Li, Wei-guo
    Chen, Teng
    Li, Chao
    Ma, Xiang-yu
    Xu, Shuo
    Liu, Yi-ming
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [25] LRRK2 R1628P Variant Is a Risk Factor of Parkinson's Disease Among Han-Chinese from Mainland China
    Zhang, Zijuan
    Burgunder, Jean-Marc
    An, Xingkai
    Wu, Yan
    Chen, Wenjun
    Zhang, Jinhong
    Wang, Yingcheng
    Xu, Yanming
    Gou, Yingru
    Yuan, Guanggu
    Mao, Xueye
    Peng, Rong
    MOVEMENT DISORDERS, 2009, 24 (13) : 1902 - 1905
  • [26] The LRRK2 R1628P Variant Plays a Protective Role in Han Chinese Population with Alzheimer's Disease
    Li, Hong-Lei
    Lu, Shen-Ji
    Sun, Yi-Min
    Guo, Qi-Hao
    Sadovnick, Adele Dessa
    Wu, Zhi-Ying
    CNS NEUROSCIENCE & THERAPEUTICS, 2013, 19 (04) : 207 - 215
  • [27] The association between the LRRK2 R1628P variant and the risk of Parkinson's disease in Asian: a meta-analysis
    Wang, Xiaoli
    Zhang, Xiaona
    Xue, Li
    Xie, Anmu
    NEUROSCIENCE LETTERS, 2016, 623 : 22 - 27
  • [28] Lrrk2 R1628P variant is a risk factor for essential tremor
    Chao, Yin Xia
    Ng, Ebonne Yulin
    Tan, Louis
    Prakash, Kumar M.
    Au, Wing-Lok
    Zhao, Yi
    Tan, Eng-King
    SCIENTIFIC REPORTS, 2015, 5
  • [29] MAPT IVS1+124 C>G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals
    Dan, Xiaojuan
    Wang, Chaodong
    Ma, Jinghong
    Feng, Xiuli
    Wang, Tao
    Zheng, Zheng
    Chan, Piu
    NEUROBIOLOGY OF AGING, 2014, 35 (07) : 1780.e7 - 1780.e10
  • [30] The Association between LRRK2 G2385R and Phenotype of Parkinson's Disease in Asian Population: A Meta-Analysis of Comparative Studies
    Di, Wei
    Zeng, Zhiyong
    Li, Jingyan
    Liu, Xiaoling
    Bo, Minzhi
    Lv, Hua
    PARKINSONS DISEASE, 2018, 2018